Medica Group PLC Director/PDMR Shareholding (0342F)
November 12 2020 - 2:00AM
UK Regulatory
TIDMMGP
RNS Number : 0342F
Medica Group PLC
12 November 2020
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 10 November
2020, the PDMR listed below was granted options over ordinary
shares of 0.2p each in the Company under the Company's Performance
Share Plan 2017 at a nil exercise price:
Name of PDMR Number of shares subject
to option
Richard Jones 443,077
The notification set out below is provided in accordance with
the requirements of the EU Market Abuse Regulation and set out more
details of the transactions.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mr Richard Jones
---------------------------------------- --------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------
a) Position/status Chief Financial Officer
---------------------------------------- --------------------------------------------------
b) Initial notification Initial notification in each case
/Amendment
---------------------------------------- --------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------------------------
a) Name Medica Group PLC
---------------------------------------- --------------------------------------------------
b) LEI 213800B8XE5FUSZF5Z16
---------------------------------------- --------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
--------------------------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.2p each in the capital
financial instrument, of the Company ("Shares")
type of instrument
b) Nature of the transaction Grant of options to acquire Shares pursuant
to the Company's Performance Share Plan
2017
---------------------------------------- --------------------------------------------------
c) Price(s) and volume(s) Exercise Price
nil
d) Aggregated information N/A
e) Date of the transaction 10 November 2020
f) Place of the transaction Outside a trading venue
---------------------------------------- --------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHKKDBNABDDPDD
(END) Dow Jones Newswires
November 12, 2020 02:00 ET (07:00 GMT)
Medica (LSE:MGP)
Historical Stock Chart
From Apr 2024 to May 2024
Medica (LSE:MGP)
Historical Stock Chart
From May 2023 to May 2024
